BioAdvance - Board of Directors
About BioAdvance >> Board of Directors

Management

Barbrara S. Schilberg
Managing Director and CEO, BioAdvance

Shahram Hejazi. Ph.D.
Venture Partner, BioAdvance

Marie Lindner, M.D.
Venture Partner, BioAdvance


Board of Directors

Philip P. Gerbino, PharmD. (Board Chair)
President, University of the Sciences

Brenda D. Gavin, D.V.M. (Board Vice Chair)
Partner, Quaker BioVentures, L.P.

Frank  Baldino, Jr., Ph.D. (Past Chair)
Chairman & Chief Executive Officer, Cephalon, Inc.

John M. Daly, M.D.
Dean, Temple University School of Medicine.
Harry C. Donahoo Professor of Surgery.

John Gill
Founder, President, CEO and Director, TetraLogic Pharmaceuticals

Samuel P. Katz
Partner/CEO, Leverage LLC.

Russel E.  Kaufman, M.D. (Immediate Past Chair) 
President & CEO, The Wistar Institute

Lauren Lenfest
PA Department of Community and Economic Development
Tobacco Settlement  Investment Board, Commonwealth of Pennsylvania

Steven  Nichtberger, M.D.
President and CEO, Tengion

Arthur H. Rubenstein, M.D.
Executive Vice President of the University of Pennsylvania for the Health System, and Dean of the University of Pennsylvania School of Medicine

Hon. Mark S.  Schweiker
President, Business Process Outsourcing, PRWT Services, Inc.

Manuel  Stamatakis
CEO, Capital Management Enterprises


ex officio Members

John Sider
Deputy Secretary, Technology Investment Office
PA Department of Community and Economic Development

Everette James
Secretary, Department of Health Pennsylvania Department of Health

Barbrara S. Schilberg
Managing Director and CEO, BioAdvance